| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 72 | 2026 | 261 | 22.820 |
Why?
|
| Flavones | 38 | 2025 | 53 | 13.800 |
Why?
|
| Colitis | 25 | 2026 | 77 | 9.830 |
Why?
|
| Plant Extracts | 35 | 2026 | 130 | 9.700 |
Why?
|
| Polysaccharides | 28 | 2026 | 153 | 9.320 |
Why?
|
| Citrus | 30 | 2026 | 46 | 8.960 |
Why?
|
| Air Pollutants | 25 | 2026 | 98 | 8.950 |
Why?
|
| Colonic Neoplasms | 32 | 2024 | 219 | 8.470 |
Why?
|
| Environmental Monitoring | 33 | 2026 | 153 | 7.950 |
Why?
|
| Pleurotus | 12 | 2025 | 12 | 7.720 |
Why?
|
| Anti-Inflammatory Agents | 19 | 2025 | 165 | 6.730 |
Why?
|
| Colon | 30 | 2025 | 147 | 6.200 |
Why?
|
| Bacteria | 31 | 2026 | 336 | 6.190 |
Why?
|
| Antioxidants | 26 | 2025 | 249 | 6.050 |
Why?
|
| Curcumin | 16 | 2025 | 82 | 6.040 |
Why?
|
| Animals | 235 | 2026 | 21259 | 5.820 |
Why?
|
| Dysbiosis | 15 | 2026 | 74 | 5.810 |
Why?
|
| Mice | 135 | 2026 | 11070 | 5.150 |
Why?
|
| Anticarcinogenic Agents | 18 | 2022 | 33 | 5.060 |
Why?
|
| Fermentation | 22 | 2026 | 52 | 4.760 |
Why?
|
| Gastrointestinal Tract | 30 | 2025 | 189 | 4.430 |
Why?
|
| Particulate Matter | 17 | 2025 | 70 | 4.200 |
Why?
|
| Flavonoids | 22 | 2025 | 57 | 4.180 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 8 | 2025 | 18 | 4.140 |
Why?
|
| Carotenoids | 14 | 2026 | 67 | 4.060 |
Why?
|
| Dextran Sulfate | 17 | 2024 | 39 | 3.990 |
Why?
|
| Fatty Acids, Volatile | 15 | 2026 | 21 | 3.980 |
Why?
|
| Phenols | 15 | 2021 | 77 | 3.910 |
Why?
|
| Nanoparticles | 27 | 2026 | 544 | 3.890 |
Why?
|
| Digestion | 28 | 2026 | 159 | 3.730 |
Why?
|
| Apoptosis | 41 | 2024 | 1095 | 3.630 |
Why?
|
| Volatile Organic Compounds | 8 | 2026 | 22 | 3.540 |
Why?
|
| Dietary Fiber | 9 | 2025 | 79 | 3.340 |
Why?
|
| Benzhydryl Compounds | 9 | 2020 | 61 | 3.140 |
Why?
|
| Humans | 227 | 2026 | 64818 | 3.120 |
Why?
|
| Mice, Inbred C57BL | 43 | 2026 | 3467 | 3.110 |
Why?
|
| Biological Availability | 40 | 2026 | 208 | 3.100 |
Why?
|
| Pesticides | 8 | 2026 | 58 | 3.070 |
Why?
|
| Emulsions | 42 | 2024 | 493 | 2.970 |
Why?
|
| Air Pollution | 7 | 2026 | 40 | 2.900 |
Why?
|
| beta Carotene | 12 | 2020 | 66 | 2.820 |
Why?
|
| China | 34 | 2026 | 175 | 2.810 |
Why?
|
| Probiotics | 10 | 2025 | 57 | 2.760 |
Why?
|
| Garlic | 4 | 2025 | 8 | 2.760 |
Why?
|
| Exosomes | 4 | 2026 | 53 | 2.750 |
Why?
|
| Dietary Supplements | 18 | 2025 | 234 | 2.750 |
Why?
|
| Cell Proliferation | 28 | 2026 | 1034 | 2.740 |
Why?
|
| Ozone | 4 | 2026 | 20 | 2.710 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 5 | 2026 | 84 | 2.620 |
Why?
|
| Functional Food | 9 | 2026 | 38 | 2.570 |
Why?
|
| Proteins | 9 | 2026 | 764 | 2.570 |
Why?
|
| Plant Proteins | 7 | 2021 | 92 | 2.530 |
Why?
|
| Vaccinium macrocarpon | 4 | 2020 | 5 | 2.460 |
Why?
|
| Male | 112 | 2026 | 30880 | 2.450 |
Why?
|
| Fruit | 20 | 2025 | 101 | 2.420 |
Why?
|
| Excipients | 12 | 2022 | 50 | 2.420 |
Why?
|
| Hypoglycemic Agents | 6 | 2026 | 225 | 2.400 |
Why?
|
| Inflammation | 22 | 2025 | 1186 | 2.380 |
Why?
|
| Agaricales | 4 | 2024 | 9 | 2.370 |
Why?
|
| Polyphenols | 12 | 2024 | 61 | 2.340 |
Why?
|
| Diet, High-Fat | 13 | 2026 | 180 | 2.310 |
Why?
|
| Cell Survival | 23 | 2021 | 582 | 2.310 |
Why?
|
| Metal Nanoparticles | 6 | 2024 | 190 | 2.310 |
Why?
|
| Caco-2 Cells | 22 | 2025 | 67 | 2.290 |
Why?
|
| Lipids | 13 | 2026 | 327 | 2.280 |
Why?
|
| Pectins | 9 | 2025 | 63 | 2.260 |
Why?
|
| Macrophages | 19 | 2025 | 1035 | 2.250 |
Why?
|
| Cell Line, Tumor | 39 | 2026 | 1564 | 2.240 |
Why?
|
| Catechin | 9 | 2022 | 37 | 2.210 |
Why?
|
| RAW 264.7 Cells | 15 | 2025 | 50 | 2.160 |
Why?
|
| Signal Transduction | 36 | 2025 | 3137 | 2.160 |
Why?
|
| Neurons | 13 | 2021 | 932 | 2.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 8 | 2020 | 44 | 2.100 |
Why?
|
| Drug Delivery Systems | 20 | 2024 | 333 | 2.090 |
Why?
|
| Vegetables | 8 | 2025 | 68 | 2.070 |
Why?
|
| Peptides | 11 | 2026 | 587 | 2.070 |
Why?
|
| Particle Size | 25 | 2025 | 428 | 2.060 |
Why?
|
| Feces | 9 | 2025 | 118 | 1.980 |
Why?
|
| Lipid Metabolism | 15 | 2026 | 225 | 1.950 |
Why?
|
| Triglycerides | 13 | 2021 | 248 | 1.900 |
Why?
|
| Antineoplastic Agents | 9 | 2021 | 642 | 1.860 |
Why?
|
| Xanthophylls | 6 | 2026 | 26 | 1.860 |
Why?
|
| Water Pollutants, Chemical | 6 | 2026 | 42 | 1.820 |
Why?
|
| Piper nigrum | 3 | 2026 | 5 | 1.800 |
Why?
|
| Seasons | 19 | 2026 | 138 | 1.800 |
Why?
|
| Nitric Oxide Synthase Type II | 11 | 2021 | 60 | 1.770 |
Why?
|
| Endocrine Disruptors | 6 | 2020 | 78 | 1.730 |
Why?
|
| Chromatography, High Pressure Liquid | 15 | 2025 | 221 | 1.710 |
Why?
|
| Food Handling | 9 | 2026 | 58 | 1.670 |
Why?
|
| Food Additives | 4 | 2026 | 27 | 1.650 |
Why?
|
| Stilbenes | 5 | 2022 | 22 | 1.630 |
Why?
|
| Rivers | 7 | 2026 | 22 | 1.630 |
Why?
|
| Titanium | 6 | 2025 | 59 | 1.620 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2024 | 39 | 1.590 |
Why?
|
| Colorectal Neoplasms | 7 | 2022 | 286 | 1.580 |
Why?
|
| Water | 12 | 2026 | 313 | 1.570 |
Why?
|
| Pectinidae | 4 | 2022 | 8 | 1.550 |
Why?
|
| Sulfates | 5 | 2021 | 14 | 1.530 |
Why?
|
| Lactobacillales | 4 | 2025 | 5 | 1.520 |
Why?
|
| Immunologic Factors | 3 | 2025 | 107 | 1.470 |
Why?
|
| Starch | 4 | 2026 | 83 | 1.470 |
Why?
|
| Lung Neoplasms | 10 | 2025 | 702 | 1.470 |
Why?
|
| Metabolomics | 5 | 2024 | 59 | 1.440 |
Why?
|
| Rats | 30 | 2024 | 1989 | 1.440 |
Why?
|
| HCT116 Cells | 14 | 2020 | 49 | 1.430 |
Why?
|
| Oryza | 5 | 2025 | 36 | 1.430 |
Why?
|
| Carcinogenesis | 10 | 2024 | 133 | 1.420 |
Why?
|
| Ganglia, Spinal | 6 | 2014 | 30 | 1.420 |
Why?
|
| Environmental Pollutants | 5 | 2022 | 97 | 1.400 |
Why?
|
| Isothiocyanates | 4 | 2019 | 18 | 1.400 |
Why?
|
| Methamphetamine | 7 | 2020 | 25 | 1.380 |
Why?
|
| Cell Cycle Checkpoints | 7 | 2020 | 47 | 1.370 |
Why?
|
| Emulsifying Agents | 8 | 2019 | 83 | 1.360 |
Why?
|
| Fungal Proteins | 2 | 2025 | 152 | 1.340 |
Why?
|
| Spermatocytes | 4 | 2015 | 16 | 1.320 |
Why?
|
| Fragaria | 2 | 2021 | 6 | 1.310 |
Why?
|
| Biopolymers | 5 | 2025 | 72 | 1.300 |
Why?
|
| Spinacia oleracea | 3 | 2019 | 12 | 1.300 |
Why?
|
| Cytokines | 16 | 2024 | 951 | 1.300 |
Why?
|
| Liver | 9 | 2024 | 868 | 1.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 184 | 1.280 |
Why?
|
| MAP Kinase Signaling System | 7 | 2020 | 234 | 1.270 |
Why?
|
| Lipopolysaccharides | 10 | 2023 | 620 | 1.260 |
Why?
|
| Intestinal Mucosa | 9 | 2025 | 249 | 1.250 |
Why?
|
| Calcium | 6 | 2022 | 581 | 1.230 |
Why?
|
| Tea | 7 | 2024 | 32 | 1.220 |
Why?
|
| Food | 3 | 2021 | 76 | 1.220 |
Why?
|
| NF-kappa B | 12 | 2024 | 434 | 1.200 |
Why?
|
| Drug Synergism | 13 | 2020 | 142 | 1.200 |
Why?
|
| Tandem Mass Spectrometry | 12 | 2023 | 135 | 1.190 |
Why?
|
| Moths | 2 | 2026 | 27 | 1.180 |
Why?
|
| Phytochemicals | 6 | 2025 | 22 | 1.180 |
Why?
|
| Basidiomycota | 2 | 2025 | 3 | 1.150 |
Why?
|
| Models, Biological | 21 | 2020 | 1192 | 1.150 |
Why?
|
| Environmental Exposure | 4 | 2025 | 226 | 1.150 |
Why?
|
| Prebiotics | 6 | 2025 | 18 | 1.140 |
Why?
|
| Neoplasms | 9 | 2025 | 1362 | 1.140 |
Why?
|
| Carbon | 5 | 2025 | 52 | 1.130 |
Why?
|
| Corn Oil | 8 | 2022 | 51 | 1.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2026 | 730 | 1.120 |
Why?
|
| Insulin | 6 | 2019 | 695 | 1.110 |
Why?
|
| Flavoring Agents | 2 | 2026 | 15 | 1.110 |
Why?
|
| Plant Oils | 8 | 2025 | 63 | 1.100 |
Why?
|
| Escherichia coli Proteins | 5 | 2026 | 275 | 1.090 |
Why?
|
| Rubus | 3 | 2024 | 3 | 1.090 |
Why?
|
| Escherichia coli | 6 | 2026 | 706 | 1.080 |
Why?
|
| Micelles | 8 | 2022 | 83 | 1.080 |
Why?
|
| Fructans | 2 | 2024 | 2 | 1.080 |
Why?
|
| Caseins | 7 | 2022 | 42 | 1.080 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2019 | 62 | 1.070 |
Why?
|
| Diet | 12 | 2025 | 533 | 1.070 |
Why?
|
| Interleukin-6 | 11 | 2025 | 323 | 1.070 |
Why?
|
| Cerebral Cortex | 4 | 2021 | 267 | 1.060 |
Why?
|
| Nitric Oxide | 10 | 2021 | 164 | 1.060 |
Why?
|
| Dietary Fats | 3 | 2026 | 178 | 1.020 |
Why?
|
| Carcinogens | 6 | 2022 | 33 | 1.020 |
Why?
|
| Microglia | 5 | 2020 | 250 | 1.020 |
Why?
|
| Pasteurella Infections | 2 | 2023 | 2 | 1.010 |
Why?
|
| Pasteurella multocida | 2 | 2023 | 2 | 1.010 |
Why?
|
| Estradiol | 6 | 2015 | 259 | 1.000 |
Why?
|
| Drugs, Chinese Herbal | 5 | 2023 | 12 | 1.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2024 | 53 | 0.990 |
Why?
|
| Cell Cycle | 11 | 2020 | 396 | 0.990 |
Why?
|
| Pyrethrins | 4 | 2012 | 9 | 0.980 |
Why?
|
| Cities | 8 | 2026 | 32 | 0.980 |
Why?
|
| Daucus carota | 4 | 2024 | 9 | 0.980 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2020 | 853 | 0.970 |
Why?
|
| Structure-Activity Relationship | 12 | 2025 | 354 | 0.970 |
Why?
|
| Disease Models, Animal | 21 | 2024 | 2278 | 0.970 |
Why?
|
| Insecticide Resistance | 1 | 2026 | 11 | 0.960 |
Why?
|
| Organic Chemicals | 1 | 2026 | 26 | 0.960 |
Why?
|
| Alcoholic Beverages | 1 | 2026 | 7 | 0.960 |
Why?
|
| Nitriles | 4 | 2012 | 82 | 0.960 |
Why?
|
| Avena | 3 | 2024 | 7 | 0.950 |
Why?
|
| Anti-Bacterial Agents | 9 | 2024 | 796 | 0.950 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2024 | 17 | 0.950 |
Why?
|
| Bacterial Proteins | 5 | 2026 | 737 | 0.940 |
Why?
|
| Gonads | 4 | 2022 | 18 | 0.940 |
Why?
|
| Homeostasis | 6 | 2026 | 377 | 0.940 |
Why?
|
| Fatty Alcohols | 1 | 2025 | 1 | 0.930 |
Why?
|
| Catechols | 1 | 2025 | 7 | 0.930 |
Why?
|
| Lactobacillus | 2 | 2025 | 7 | 0.930 |
Why?
|
| Intestine, Small | 5 | 2018 | 80 | 0.930 |
Why?
|
| Guaiacol | 1 | 2025 | 1 | 0.930 |
Why?
|
| Calmodulin | 3 | 2015 | 23 | 0.930 |
Why?
|
| Wind | 2 | 2024 | 4 | 0.920 |
Why?
|
| Cyclooxygenase 2 | 9 | 2021 | 61 | 0.920 |
Why?
|
| Machine Learning | 2 | 2025 | 192 | 0.920 |
Why?
|
| Reactive Oxygen Species | 15 | 2025 | 237 | 0.920 |
Why?
|
| Insecticides | 1 | 2026 | 45 | 0.920 |
Why?
|
| Hemolysin Proteins | 1 | 2026 | 45 | 0.920 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 4 | 2020 | 33 | 0.910 |
Why?
|
| Dexmedetomidine | 2 | 2016 | 10 | 0.910 |
Why?
|
| Free Radical Scavengers | 4 | 2017 | 22 | 0.910 |
Why?
|
| Glycosides | 2 | 2024 | 4 | 0.910 |
Why?
|
| Linoleic Acid | 2 | 2023 | 19 | 0.900 |
Why?
|
| Waste Products | 1 | 2025 | 3 | 0.900 |
Why?
|
| Endotoxins | 1 | 2026 | 81 | 0.900 |
Why?
|
| Bacteroides | 1 | 2025 | 10 | 0.900 |
Why?
|
| Tropomyosin | 6 | 2019 | 37 | 0.890 |
Why?
|
| Glucose | 8 | 2021 | 476 | 0.890 |
Why?
|
| Calcium Channel Blockers | 3 | 2011 | 58 | 0.890 |
Why?
|
| Food Technology | 3 | 2024 | 39 | 0.890 |
Why?
|
| Soy Foods | 2 | 2024 | 4 | 0.890 |
Why?
|
| Trigonella | 1 | 2024 | 1 | 0.890 |
Why?
|
| Coordination Complexes | 1 | 2025 | 9 | 0.890 |
Why?
|
| Carrageenan | 1 | 2025 | 18 | 0.880 |
Why?
|
| Candida | 3 | 2025 | 37 | 0.880 |
Why?
|
| Methylamines | 1 | 2024 | 11 | 0.880 |
Why?
|
| Carnitine | 1 | 2024 | 19 | 0.870 |
Why?
|
| Drug Carriers | 8 | 2024 | 188 | 0.860 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2024 | 622 | 0.860 |
Why?
|
| Carbon Isotopes | 1 | 2024 | 17 | 0.860 |
Why?
|
| Oxidative Stress | 9 | 2025 | 319 | 0.860 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2024 | 215 | 0.860 |
Why?
|
| Hydrogen-Ion Concentration | 10 | 2025 | 463 | 0.860 |
Why?
|
| Microbiota | 7 | 2026 | 168 | 0.850 |
Why?
|
| Phosphopeptides | 3 | 2022 | 8 | 0.850 |
Why?
|
| Hirudins | 1 | 2024 | 12 | 0.850 |
Why?
|
| Bifidobacterium pseudocatenulatum | 1 | 2024 | 1 | 0.850 |
Why?
|
| Cell Line | 19 | 2021 | 2019 | 0.850 |
Why?
|
| Syzygium | 1 | 2024 | 1 | 0.840 |
Why?
|
| Glucans | 2 | 2025 | 66 | 0.840 |
Why?
|
| Edible Grain | 2 | 2021 | 27 | 0.840 |
Why?
|
| Pyridones | 1 | 2024 | 42 | 0.830 |
Why?
|
| tau Proteins | 3 | 2020 | 208 | 0.830 |
Why?
|
| Azoxymethane | 10 | 2019 | 15 | 0.820 |
Why?
|
| Biotransformation | 6 | 2025 | 23 | 0.820 |
Why?
|
| Allergens | 6 | 2023 | 54 | 0.810 |
Why?
|
| Calcium Channels, T-Type | 3 | 2011 | 7 | 0.810 |
Why?
|
| Nanostructures | 3 | 2023 | 187 | 0.810 |
Why?
|
| Administration, Oral | 9 | 2023 | 371 | 0.810 |
Why?
|
| Molecular Structure | 12 | 2025 | 316 | 0.810 |
Why?
|
| Spectrum Analysis, Raman | 7 | 2020 | 24 | 0.800 |
Why?
|
| Brain | 8 | 2020 | 1594 | 0.800 |
Why?
|
| Medicine, Chinese Traditional | 2 | 2023 | 6 | 0.800 |
Why?
|
| Oxidation-Reduction | 13 | 2025 | 324 | 0.790 |
Why?
|
| Food Storage | 3 | 2019 | 20 | 0.790 |
Why?
|
| Peyer's Patches | 3 | 2018 | 34 | 0.790 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 112 | 0.780 |
Why?
|
| Blood Platelets | 1 | 2024 | 108 | 0.780 |
Why?
|
| Bacterial Toxins | 1 | 2023 | 58 | 0.780 |
Why?
|
| Colitis, Ulcerative | 4 | 2024 | 76 | 0.780 |
Why?
|
| Organophosphorus Compounds | 2 | 2026 | 33 | 0.780 |
Why?
|
| Chylomicrons | 4 | 2021 | 7 | 0.770 |
Why?
|
| Resorcinols | 2 | 2020 | 5 | 0.770 |
Why?
|
| MicroRNAs | 3 | 2026 | 709 | 0.770 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2013 | 17 | 0.760 |
Why?
|
| Voltage-Gated Sodium Channels | 2 | 2013 | 2 | 0.760 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2025 | 602 | 0.760 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 29 | 0.750 |
Why?
|
| Protective Agents | 2 | 2020 | 12 | 0.750 |
Why?
|
| Mice, Inbred Strains | 6 | 2020 | 185 | 0.750 |
Why?
|
| Fish Proteins | 2 | 2019 | 10 | 0.750 |
Why?
|
| Neoplasms, Experimental | 3 | 2019 | 77 | 0.750 |
Why?
|
| Molecular Weight | 5 | 2025 | 193 | 0.750 |
Why?
|
| Zein | 4 | 2024 | 36 | 0.740 |
Why?
|
| Proteome | 2 | 2020 | 151 | 0.730 |
Why?
|
| Mice, Inbred ICR | 7 | 2021 | 33 | 0.730 |
Why?
|
| Bombyx | 1 | 2022 | 10 | 0.730 |
Why?
|
| Female | 52 | 2026 | 33854 | 0.720 |
Why?
|
| Fabaceae | 1 | 2021 | 10 | 0.710 |
Why?
|
| Sasa | 1 | 2021 | 1 | 0.710 |
Why?
|
| Xylans | 1 | 2021 | 5 | 0.710 |
Why?
|
| Glycation End Products, Advanced | 4 | 2025 | 19 | 0.710 |
Why?
|
| Constipation | 1 | 2021 | 15 | 0.710 |
Why?
|
| Luteolin | 2 | 2018 | 2 | 0.700 |
Why?
|
| Flammulina | 1 | 2021 | 1 | 0.700 |
Why?
|
| Nitrosamines | 3 | 2019 | 9 | 0.700 |
Why?
|
| Interleukin-1beta | 5 | 2025 | 272 | 0.690 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2014 | 202 | 0.690 |
Why?
|
| Aquaporins | 1 | 2021 | 6 | 0.690 |
Why?
|
| Polymers | 4 | 2024 | 331 | 0.690 |
Why?
|
| Threonine | 1 | 2021 | 15 | 0.690 |
Why?
|
| Hypolipidemic Agents | 1 | 2021 | 25 | 0.680 |
Why?
|
| Skin | 3 | 2019 | 415 | 0.680 |
Why?
|
| Lactococcus lactis | 2 | 2020 | 8 | 0.680 |
Why?
|
| Temperature | 7 | 2024 | 314 | 0.680 |
Why?
|
| Alanine | 1 | 2021 | 48 | 0.680 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2020 | 155 | 0.680 |
Why?
|
| Hippocampus | 2 | 2020 | 274 | 0.670 |
Why?
|
| Capsella | 1 | 2020 | 1 | 0.670 |
Why?
|
| Serine | 1 | 2021 | 90 | 0.670 |
Why?
|
| DNA, Bacterial | 3 | 2019 | 260 | 0.660 |
Why?
|
| Eating | 3 | 2024 | 137 | 0.650 |
Why?
|
| Growth Inhibitors | 2 | 2018 | 24 | 0.650 |
Why?
|
| Pneumonia | 1 | 2023 | 291 | 0.650 |
Why?
|
| Coriolaceae | 1 | 2020 | 1 | 0.650 |
Why?
|
| Bivalvia | 1 | 2020 | 20 | 0.650 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2018 | 73 | 0.650 |
Why?
|
| Lactoglobulins | 3 | 2019 | 52 | 0.650 |
Why?
|
| Mannitol | 1 | 2020 | 15 | 0.640 |
Why?
|
| Pyrazoles | 5 | 2024 | 87 | 0.640 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 9 | 0.640 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 146 | 0.640 |
Why?
|
| Protein Phosphatase 2 | 1 | 2020 | 11 | 0.640 |
Why?
|
| Epithelial Cells | 4 | 2018 | 410 | 0.630 |
Why?
|
| Receptor, Insulin | 2 | 2017 | 52 | 0.630 |
Why?
|
| Membrane Proteins | 6 | 2026 | 918 | 0.630 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2020 | 22 | 0.630 |
Why?
|
| Obesity | 7 | 2025 | 1264 | 0.630 |
Why?
|
| Fatigue | 1 | 2020 | 113 | 0.620 |
Why?
|
| Edema | 2 | 2019 | 42 | 0.620 |
Why?
|
| Gold | 3 | 2024 | 235 | 0.620 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 5 | 2007 | 9 | 0.610 |
Why?
|
| Limonins | 1 | 2019 | 2 | 0.610 |
Why?
|
| Polylysine | 2 | 2017 | 49 | 0.610 |
Why?
|
| Hypertension | 3 | 2016 | 608 | 0.610 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2017 | 61 | 0.610 |
Why?
|
| Ion Channels | 4 | 2026 | 92 | 0.610 |
Why?
|
| Gastropoda | 1 | 2019 | 1 | 0.610 |
Why?
|
| Iron Chelating Agents | 1 | 2019 | 7 | 0.610 |
Why?
|
| Antifungal Agents | 2 | 2019 | 125 | 0.610 |
Why?
|
| Aerosols | 9 | 2022 | 46 | 0.610 |
Why?
|
| Chitosan | 6 | 2022 | 87 | 0.610 |
Why?
|
| Thiamine | 1 | 2019 | 21 | 0.600 |
Why?
|
| Palaemonidae | 4 | 2019 | 5 | 0.600 |
Why?
|
| Fish Oils | 1 | 2019 | 43 | 0.600 |
Why?
|
| Enterocytes | 3 | 2021 | 25 | 0.600 |
Why?
|
| Sucrose | 1 | 2019 | 29 | 0.600 |
Why?
|
| Food Hypersensitivity | 4 | 2025 | 26 | 0.600 |
Why?
|
| Glucuronidase | 3 | 2022 | 25 | 0.600 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2016 | 35 | 0.590 |
Why?
|
| Phytotherapy | 2 | 2016 | 34 | 0.590 |
Why?
|
| Intestinal Absorption | 5 | 2026 | 32 | 0.590 |
Why?
|
| Adenosine | 2 | 2024 | 78 | 0.580 |
Why?
|
| Chemoprevention | 2 | 2017 | 26 | 0.580 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 235 | 0.580 |
Why?
|
| Flunarizine | 2 | 2010 | 2 | 0.570 |
Why?
|
| Galactose | 3 | 2023 | 12 | 0.570 |
Why?
|
| Membrane Potentials | 4 | 2014 | 138 | 0.570 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2010 | 214 | 0.570 |
Why?
|
| Iron | 1 | 2019 | 150 | 0.570 |
Why?
|
| Nutritive Value | 5 | 2026 | 36 | 0.570 |
Why?
|
| Diterpenes | 2 | 2023 | 13 | 0.560 |
Why?
|
| Phaseolus | 1 | 2018 | 1 | 0.560 |
Why?
|
| Carboxylesterase | 1 | 2018 | 4 | 0.560 |
Why?
|
| Food Irradiation | 1 | 2018 | 1 | 0.560 |
Why?
|
| Metals | 2 | 2021 | 65 | 0.560 |
Why?
|
| Organophosphates | 1 | 2018 | 14 | 0.560 |
Why?
|
| Carbamates | 1 | 2018 | 26 | 0.560 |
Why?
|
| Food Quality | 1 | 2018 | 11 | 0.560 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 5 | 0.550 |
Why?
|
| Shab Potassium Channels | 1 | 2018 | 2 | 0.550 |
Why?
|
| Calcium Compounds | 1 | 2017 | 5 | 0.550 |
Why?
|
| Intestinal Diseases | 3 | 2024 | 36 | 0.550 |
Why?
|
| Central Nervous System Stimulants | 4 | 2020 | 66 | 0.550 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 17 | 0.540 |
Why?
|
| Enzyme Assays | 1 | 2017 | 13 | 0.540 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2024 | 105 | 0.540 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 194 | 0.540 |
Why?
|
| Zea mays | 2 | 2024 | 30 | 0.530 |
Why?
|
| Bioreactors | 3 | 2025 | 36 | 0.530 |
Why?
|
| Heme Oxygenase-1 | 4 | 2019 | 19 | 0.530 |
Why?
|
| Phosphorylation | 8 | 2020 | 959 | 0.530 |
Why?
|
| Risk Assessment | 7 | 2026 | 2091 | 0.530 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2025 | 83 | 0.530 |
Why?
|
| HT29 Cells | 6 | 2018 | 28 | 0.530 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2017 | 50 | 0.530 |
Why?
|
| Diterpenes, Kaurane | 1 | 2017 | 2 | 0.520 |
Why?
|
| Cysteine | 4 | 2019 | 107 | 0.510 |
Why?
|
| Onions | 2 | 2007 | 2 | 0.510 |
Why?
|
| Surface-Active Agents | 4 | 2021 | 115 | 0.510 |
Why?
|
| Fatty Acids | 4 | 2019 | 197 | 0.510 |
Why?
|
| Fats | 1 | 2017 | 20 | 0.500 |
Why?
|
| Magnesium | 1 | 2017 | 54 | 0.500 |
Why?
|
| Myocardium | 2 | 2016 | 301 | 0.500 |
Why?
|
| Alkanesulfonic Acids | 2 | 2024 | 10 | 0.500 |
Why?
|
| Heptanoic Acids | 4 | 2010 | 22 | 0.500 |
Why?
|
| Dietary Carbohydrates | 3 | 2025 | 62 | 0.500 |
Why?
|
| Intestines | 4 | 2025 | 178 | 0.490 |
Why?
|
| Pyrroles | 4 | 2010 | 49 | 0.490 |
Why?
|
| Glutathione Transferase | 2 | 2006 | 38 | 0.490 |
Why?
|
| Polymerization | 4 | 2024 | 36 | 0.490 |
Why?
|
| SELEX Aptamer Technique | 2 | 2026 | 5 | 0.490 |
Why?
|
| Copper | 5 | 2025 | 57 | 0.490 |
Why?
|
| Tobacco Products | 1 | 2017 | 63 | 0.480 |
Why?
|
| Sulfonamides | 4 | 2013 | 136 | 0.480 |
Why?
|
| Chemical Phenomena | 3 | 2025 | 96 | 0.480 |
Why?
|
| Anti-Infective Agents, Local | 4 | 2022 | 29 | 0.480 |
Why?
|
| Gene Expression Regulation | 10 | 2024 | 1629 | 0.480 |
Why?
|
| Models, Chemical | 3 | 2015 | 134 | 0.480 |
Why?
|
| Ear | 1 | 2015 | 9 | 0.480 |
Why?
|
| Up-Regulation | 7 | 2021 | 373 | 0.470 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 179 | 0.470 |
Why?
|
| Dermatitis, Contact | 1 | 2015 | 12 | 0.470 |
Why?
|
| Hair Preparations | 1 | 2015 | 2 | 0.470 |
Why?
|
| DNA, Catalytic | 2 | 2026 | 4 | 0.470 |
Why?
|
| Larva | 3 | 2026 | 157 | 0.460 |
Why?
|
| Transcriptome | 4 | 2024 | 395 | 0.460 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2014 | 48 | 0.460 |
Why?
|
| Solubility | 12 | 2025 | 191 | 0.460 |
Why?
|
| Elastic Modulus | 1 | 2015 | 39 | 0.460 |
Why?
|
| Food Analysis | 3 | 2020 | 31 | 0.450 |
Why?
|
| Capsules | 3 | 2025 | 33 | 0.450 |
Why?
|
| Cholesterol | 3 | 2021 | 261 | 0.450 |
Why?
|
| Gels | 3 | 2026 | 77 | 0.450 |
Why?
|
| Caenorhabditis elegans | 3 | 2025 | 706 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2024 | 178 | 0.450 |
Why?
|
| Spinal Fusion | 3 | 2026 | 156 | 0.450 |
Why?
|
| Precancerous Conditions | 2 | 2023 | 74 | 0.450 |
Why?
|
| Proteomics | 5 | 2020 | 291 | 0.450 |
Why?
|
| Cell Membrane | 4 | 2026 | 504 | 0.440 |
Why?
|
| Herbicides | 2 | 2016 | 19 | 0.440 |
Why?
|
| Methanosarcina | 2 | 2025 | 2 | 0.440 |
Why?
|
| Hair | 1 | 2015 | 80 | 0.440 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2019 | 312 | 0.440 |
Why?
|
| Nanospheres | 2 | 2025 | 8 | 0.440 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 51 | 0.440 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 161 | 0.440 |
Why?
|
| RNA, Messenger | 8 | 2022 | 1576 | 0.440 |
Why?
|
| Dust | 3 | 2024 | 42 | 0.430 |
Why?
|
| Oligosaccharides | 5 | 2023 | 55 | 0.430 |
Why?
|
| Cellulose | 3 | 2024 | 46 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2013 | 58 | 0.420 |
Why?
|
| Nanocomposites | 2 | 2025 | 28 | 0.420 |
Why?
|
| Fluorocarbons | 1 | 2015 | 51 | 0.420 |
Why?
|
| Oils, Volatile | 3 | 2020 | 23 | 0.420 |
Why?
|
| Sulfoxides | 4 | 2019 | 15 | 0.420 |
Why?
|
| Glucose Tolerance Test | 3 | 2020 | 97 | 0.420 |
Why?
|
| Rats, Inbred F344 | 6 | 2018 | 56 | 0.410 |
Why?
|
| Oleic Acid | 1 | 2013 | 20 | 0.410 |
Why?
|
| Lymph | 1 | 2013 | 10 | 0.410 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2020 | 3 | 0.410 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2019 | 87 | 0.410 |
Why?
|
| Bread | 2 | 2026 | 5 | 0.400 |
Why?
|
| Tryptophan | 3 | 2023 | 56 | 0.400 |
Why?
|
| Diabetes Mellitus | 2 | 2025 | 554 | 0.400 |
Why?
|
| Nanotechnology | 4 | 2025 | 139 | 0.400 |
Why?
|
| Cervical Vertebrae | 2 | 2026 | 119 | 0.400 |
Why?
|
| Luminescence | 2 | 2024 | 19 | 0.400 |
Why?
|
| Citrus sinensis | 3 | 2010 | 11 | 0.400 |
Why?
|
| Indoles | 3 | 2026 | 111 | 0.400 |
Why?
|
| Catalysis | 5 | 2025 | 163 | 0.400 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2013 | 7 | 0.400 |
Why?
|
| Phenethylamines | 1 | 2013 | 10 | 0.400 |
Why?
|
| Nephritis | 1 | 2013 | 11 | 0.390 |
Why?
|
| Mass Spectrometry | 3 | 2025 | 295 | 0.390 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 37 | 0.390 |
Why?
|
| Drug Stability | 6 | 2025 | 144 | 0.390 |
Why?
|
| Patch-Clamp Techniques | 5 | 2013 | 133 | 0.390 |
Why?
|
| Biophysical Phenomena | 1 | 2013 | 23 | 0.390 |
Why?
|
| Taste | 2 | 2026 | 39 | 0.390 |
Why?
|
| Metal-Organic Frameworks | 2 | 2024 | 8 | 0.390 |
Why?
|
| Blotting, Western | 6 | 2018 | 609 | 0.380 |
Why?
|
| Milk, Human | 3 | 2019 | 99 | 0.380 |
Why?
|
| Calcium Channels | 1 | 2013 | 103 | 0.380 |
Why?
|
| Kinetics | 5 | 2020 | 757 | 0.380 |
Why?
|
| Cholesterol, Dietary | 2 | 2023 | 29 | 0.380 |
Why?
|
| Superoxide Dismutase | 3 | 2020 | 221 | 0.380 |
Why?
|
| Nephritis, Interstitial | 1 | 2012 | 15 | 0.380 |
Why?
|
| Phylogeny | 3 | 2025 | 386 | 0.380 |
Why?
|
| Occipital Bone | 2 | 2026 | 5 | 0.370 |
Why?
|
| Click Chemistry | 2 | 2024 | 10 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 509 | 0.370 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 3 | 2021 | 39 | 0.370 |
Why?
|
| Thiocyanates | 1 | 2012 | 6 | 0.370 |
Why?
|
| Vehicle Emissions | 5 | 2025 | 23 | 0.360 |
Why?
|
| Anti-Infective Agents | 4 | 2023 | 151 | 0.360 |
Why?
|
| Triclosan | 3 | 2022 | 9 | 0.360 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 367 | 0.360 |
Why?
|
| Molybdenum | 2 | 2021 | 5 | 0.360 |
Why?
|
| Blood Glucose | 4 | 2026 | 497 | 0.360 |
Why?
|
| Fructose | 3 | 2021 | 37 | 0.360 |
Why?
|
| Photochemotherapy | 2 | 2023 | 46 | 0.360 |
Why?
|
| Infertility, Male | 1 | 2012 | 58 | 0.350 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2025 | 75 | 0.350 |
Why?
|
| Biodiversity | 4 | 2026 | 48 | 0.350 |
Why?
|
| Spermatogenesis | 1 | 2012 | 76 | 0.350 |
Why?
|
| Dinoprostone | 5 | 2020 | 41 | 0.350 |
Why?
|
| Shellfish Hypersensitivity | 3 | 2019 | 4 | 0.350 |
Why?
|
| Stomach | 3 | 2024 | 87 | 0.350 |
Why?
|
| Humic Substances | 2 | 2024 | 5 | 0.350 |
Why?
|
| Ions | 3 | 2022 | 54 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 7 | 2021 | 869 | 0.340 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 129 | 0.340 |
Why?
|
| Litchi | 2 | 2021 | 2 | 0.340 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 66 | 0.340 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2019 | 46 | 0.340 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2011 | 18 | 0.340 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2011 | 19 | 0.340 |
Why?
|
| Metabolome | 5 | 2024 | 36 | 0.340 |
Why?
|
| Holidays | 2 | 2022 | 2 | 0.330 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 38 | 0.330 |
Why?
|
| Polysorbates | 4 | 2018 | 43 | 0.330 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2024 | 11 | 0.330 |
Why?
|
| Gene Expression | 5 | 2022 | 852 | 0.330 |
Why?
|
| Mitochondria | 6 | 2025 | 401 | 0.330 |
Why?
|
| DNA | 2 | 2025 | 852 | 0.330 |
Why?
|
| Sciatic Neuropathy | 1 | 2010 | 3 | 0.330 |
Why?
|
| Plant Leaves | 3 | 2022 | 22 | 0.330 |
Why?
|
| Urine | 2 | 2024 | 45 | 0.320 |
Why?
|
| Molecular Imprinting | 1 | 2010 | 6 | 0.320 |
Why?
|
| Action Potentials | 1 | 2011 | 113 | 0.320 |
Why?
|
| Sulfonylurea Compounds | 1 | 2010 | 12 | 0.320 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2020 | 350 | 0.320 |
Why?
|
| Chromatography, Liquid | 6 | 2023 | 116 | 0.320 |
Why?
|
| Drug Compounding | 5 | 2025 | 79 | 0.320 |
Why?
|
| Solvents | 3 | 2023 | 60 | 0.310 |
Why?
|
| Electrochemical Techniques | 1 | 2009 | 21 | 0.310 |
Why?
|
| Amyloid beta-Peptides | 3 | 2018 | 319 | 0.310 |
Why?
|
| Adsorption | 4 | 2024 | 87 | 0.310 |
Why?
|
| Spermatozoa | 1 | 2012 | 267 | 0.310 |
Why?
|
| Fluorescent Dyes | 2 | 2025 | 201 | 0.310 |
Why?
|
| Cosmetics | 3 | 2024 | 16 | 0.300 |
Why?
|
| Allium | 3 | 2014 | 3 | 0.300 |
Why?
|
| Acute Lung Injury | 2 | 2023 | 45 | 0.300 |
Why?
|
| Sewage | 3 | 2024 | 5 | 0.300 |
Why?
|
| Protons | 2 | 2026 | 67 | 0.300 |
Why?
|
| Agriculture | 3 | 2025 | 31 | 0.300 |
Why?
|
| Time Factors | 10 | 2020 | 3750 | 0.300 |
Why?
|
| Young Adult | 7 | 2025 | 4782 | 0.300 |
Why?
|
| Roseobacter | 2 | 2025 | 2 | 0.290 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2009 | 42 | 0.290 |
Why?
|
| Bile Acids and Salts | 2 | 2026 | 25 | 0.290 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 45 | 0.290 |
Why?
|
| Insulin Resistance | 5 | 2026 | 414 | 0.290 |
Why?
|
| Pregnancy | 6 | 2020 | 2365 | 0.290 |
Why?
|
| Random Allocation | 4 | 2020 | 200 | 0.290 |
Why?
|
| Atmosphere | 2 | 2025 | 3 | 0.290 |
Why?
|
| Soil Pollutants | 3 | 2024 | 25 | 0.290 |
Why?
|
| Mechanical Phenomena | 2 | 2019 | 23 | 0.290 |
Why?
|
| Food Microbiology | 2 | 2019 | 43 | 0.280 |
Why?
|
| Acetylcysteine | 2 | 2019 | 25 | 0.280 |
Why?
|
| Cell Division | 2 | 2010 | 448 | 0.280 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 5 | 2024 | 281 | 0.280 |
Why?
|
| Platybasia | 2 | 2025 | 2 | 0.280 |
Why?
|
| Oceans and Seas | 2 | 2025 | 4 | 0.280 |
Why?
|
| Finite Element Analysis | 2 | 2026 | 13 | 0.280 |
Why?
|
| Cells, Cultured | 8 | 2017 | 2183 | 0.280 |
Why?
|
| Biomarkers | 7 | 2024 | 1472 | 0.280 |
Why?
|
| Phototherapy | 3 | 2023 | 33 | 0.280 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 29 | 0.280 |
Why?
|
| Lactation | 3 | 2018 | 77 | 0.280 |
Why?
|
| Neovascularization, Pathologic | 4 | 2021 | 140 | 0.280 |
Why?
|
| Gases | 3 | 2024 | 19 | 0.270 |
Why?
|
| Photosensitizing Agents | 3 | 2025 | 32 | 0.270 |
Why?
|
| Trace Elements | 2 | 2021 | 22 | 0.270 |
Why?
|
| Rain | 2 | 2025 | 2 | 0.270 |
Why?
|
| Biological Products | 2 | 2022 | 92 | 0.270 |
Why?
|
| Cell Movement | 4 | 2021 | 478 | 0.270 |
Why?
|
| Nitrogen Oxides | 2 | 2025 | 11 | 0.270 |
Why?
|
| Biological Transport | 3 | 2026 | 292 | 0.270 |
Why?
|
| Lung | 6 | 2023 | 962 | 0.270 |
Why?
|
| Lipid Droplets | 2 | 2020 | 34 | 0.270 |
Why?
|
| Waste Disposal, Fluid | 2 | 2024 | 5 | 0.270 |
Why?
|
| Enzymes | 2 | 2018 | 35 | 0.270 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2026 | 137 | 0.270 |
Why?
|
| Caspase 3 | 5 | 2018 | 108 | 0.270 |
Why?
|
| Dopamine | 2 | 2020 | 108 | 0.260 |
Why?
|
| Ultrafiltration | 2 | 2019 | 10 | 0.260 |
Why?
|
| Down-Regulation | 5 | 2017 | 324 | 0.260 |
Why?
|
| Bacteriophages | 2 | 2025 | 66 | 0.260 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2025 | 88 | 0.260 |
Why?
|
| Methanol | 1 | 2007 | 10 | 0.260 |
Why?
|
| Bacteriocins | 2 | 2025 | 23 | 0.260 |
Why?
|
| Seafood | 3 | 2023 | 14 | 0.260 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 460 | 0.260 |
Why?
|
| Calcium, Dietary | 3 | 2022 | 28 | 0.260 |
Why?
|
| Epitopes | 4 | 2023 | 291 | 0.250 |
Why?
|
| Genome, Viral | 2 | 2025 | 144 | 0.250 |
Why?
|
| Silicon Dioxide | 2 | 2024 | 63 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 686 | 0.250 |
Why?
|
| Delayed-Action Preparations | 3 | 2025 | 120 | 0.250 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2021 | 110 | 0.250 |
Why?
|
| Spermatids | 1 | 2006 | 11 | 0.250 |
Why?
|
| Mice, Knockout | 7 | 2020 | 2146 | 0.250 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 2006 | 28 | 0.250 |
Why?
|
| Middle Aged | 13 | 2025 | 18163 | 0.250 |
Why?
|
| Alkaloids | 1 | 2026 | 8 | 0.250 |
Why?
|
| Paraquat | 2 | 2016 | 12 | 0.250 |
Why?
|
| Tongue Neoplasms | 1 | 2026 | 3 | 0.250 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2026 | 6 | 0.250 |
Why?
|
| Chenopodium quinoa | 1 | 2026 | 1 | 0.250 |
Why?
|
| Benzodioxoles | 1 | 2026 | 12 | 0.240 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2026 | 206 | 0.240 |
Why?
|
| Euphausiacea | 1 | 2026 | 1 | 0.240 |
Why?
|
| Endothelial Cells | 3 | 2023 | 206 | 0.240 |
Why?
|
| Bone-Implant Interface | 1 | 2026 | 1 | 0.240 |
Why?
|
| Water Pollution, Chemical | 1 | 2026 | 1 | 0.240 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2026 | 2 | 0.240 |
Why?
|
| Mannans | 1 | 2026 | 21 | 0.240 |
Why?
|
| Occludin | 1 | 2026 | 4 | 0.240 |
Why?
|
| Internal Fixators | 1 | 2026 | 11 | 0.240 |
Why?
|
| Polygonatum | 1 | 2026 | 1 | 0.240 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2026 | 8 | 0.240 |
Why?
|
| Recombinant Proteins | 3 | 2024 | 709 | 0.240 |
Why?
|
| Glutens | 1 | 2026 | 16 | 0.240 |
Why?
|
| Aptamers, Nucleotide | 1 | 2026 | 28 | 0.240 |
Why?
|
| CD36 Antigens | 1 | 2026 | 26 | 0.240 |
Why?
|
| Peptide Fragments | 2 | 2018 | 415 | 0.240 |
Why?
|
| Piperidines | 1 | 2026 | 73 | 0.240 |
Why?
|
| Algorithms | 3 | 2024 | 1040 | 0.240 |
Why?
|
| Selenium Compounds | 1 | 2006 | 30 | 0.240 |
Why?
|
| Cation Transport Proteins | 1 | 2026 | 22 | 0.240 |
Why?
|
| Succinates | 1 | 2025 | 10 | 0.240 |
Why?
|
| Bacillus thuringiensis | 1 | 2026 | 21 | 0.230 |
Why?
|
| Isomerism | 2 | 2023 | 29 | 0.230 |
Why?
|
| Aluminum Oxide | 1 | 2025 | 5 | 0.230 |
Why?
|
| Insect Proteins | 1 | 2026 | 82 | 0.230 |
Why?
|
| Dura Mater | 2 | 2017 | 32 | 0.230 |
Why?
|
| Sulfinic Acids | 2 | 2002 | 2 | 0.230 |
Why?
|
| Silver | 1 | 2025 | 15 | 0.230 |
Why?
|
| Glucose Transport Proteins, Facilitative | 2 | 2016 | 9 | 0.230 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2014 | 197 | 0.230 |
Why?
|
| Inhalation Exposure | 2 | 2024 | 54 | 0.230 |
Why?
|
| Atlanto-Axial Joint | 1 | 2025 | 3 | 0.230 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 121 | 0.230 |
Why?
|
| Chromatography, Thin Layer | 2 | 2020 | 16 | 0.230 |
Why?
|
| Neurotransmitter Agents | 3 | 2020 | 42 | 0.230 |
Why?
|
| Joint Dislocations | 1 | 2025 | 18 | 0.230 |
Why?
|
| Chemistry, Pharmaceutical | 3 | 2015 | 36 | 0.230 |
Why?
|
| Biomarkers, Tumor | 2 | 2026 | 521 | 0.230 |
Why?
|
| Mice, Obese | 3 | 2020 | 80 | 0.230 |
Why?
|
| Cyclonic Storms | 1 | 2025 | 23 | 0.230 |
Why?
|
| Joint Instability | 1 | 2026 | 57 | 0.230 |
Why?
|
| Microspheres | 1 | 2025 | 55 | 0.230 |
Why?
|
| Epithelial Sodium Channels | 2 | 2015 | 6 | 0.230 |
Why?
|
| Plants, Edible | 1 | 2025 | 5 | 0.230 |
Why?
|
| Microbubbles | 1 | 2025 | 3 | 0.230 |
Why?
|
| Chlorophyta | 1 | 2025 | 9 | 0.230 |
Why?
|
| Biofilms | 2 | 2023 | 85 | 0.230 |
Why?
|
| Bone Screws | 1 | 2025 | 35 | 0.220 |
Why?
|
| Aging | 2 | 2022 | 762 | 0.220 |
Why?
|
| Egg White | 2 | 2021 | 4 | 0.220 |
Why?
|
| Anti-Obesity Agents | 1 | 2025 | 16 | 0.220 |
Why?
|
| Beverages | 3 | 2018 | 68 | 0.220 |
Why?
|
| Malondialdehyde | 3 | 2020 | 15 | 0.220 |
Why?
|
| Fibroblast Growth Factors | 2 | 2016 | 77 | 0.220 |
Why?
|
| Pulmonary Edema | 2 | 2015 | 29 | 0.220 |
Why?
|
| Microviridae | 1 | 2024 | 1 | 0.220 |
Why?
|
| Volatilization | 1 | 2024 | 5 | 0.220 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 81 | 0.220 |
Why?
|
| Flame Retardants | 1 | 2024 | 6 | 0.220 |
Why?
|
| Methane | 1 | 2024 | 3 | 0.220 |
Why?
|
| Hydrogenation | 1 | 2024 | 3 | 0.220 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2020 | 30 | 0.220 |
Why?
|
| Porphyra | 1 | 2024 | 1 | 0.220 |
Why?
|
| Muscle Proteins | 2 | 2017 | 117 | 0.220 |
Why?
|
| Waste Disposal Facilities | 1 | 2024 | 1 | 0.220 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2015 | 65 | 0.220 |
Why?
|
| Feasibility Studies | 2 | 2025 | 581 | 0.220 |
Why?
|
| Phyllanthus emblica | 1 | 2024 | 1 | 0.220 |
Why?
|
| Child, Preschool | 4 | 2024 | 2052 | 0.220 |
Why?
|
| Resins, Plant | 1 | 2024 | 1 | 0.220 |
Why?
|
| Snow | 1 | 2024 | 5 | 0.210 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 219 | 0.210 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 22 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 3 | 2023 | 875 | 0.210 |
Why?
|
| Free Radicals | 3 | 2019 | 19 | 0.210 |
Why?
|
| Diarrhea | 2 | 2023 | 73 | 0.210 |
Why?
|
| Charcoal | 1 | 2024 | 6 | 0.210 |
Why?
|
| Glycosylation | 6 | 2019 | 138 | 0.210 |
Why?
|
| Odorants | 1 | 2024 | 18 | 0.210 |
Why?
|
| Histone Deacetylase 2 | 1 | 2024 | 18 | 0.210 |
Why?
|
| Industry | 1 | 2024 | 59 | 0.210 |
Why?
|
| ortho-Aminobenzoates | 1 | 2024 | 7 | 0.210 |
Why?
|
| beta-Glucans | 1 | 2024 | 51 | 0.210 |
Why?
|
| Sumoylation | 1 | 2024 | 17 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2021 | 44 | 0.210 |
Why?
|
| Bacillus | 1 | 2024 | 14 | 0.210 |
Why?
|
| Color | 1 | 2024 | 25 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 203 | 0.210 |
Why?
|
| Factor Xa Inhibitors | 1 | 2024 | 36 | 0.210 |
Why?
|
| Food Preservatives | 2 | 2025 | 8 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2025 | 124 | 0.210 |
Why?
|
| Biomimetic Materials | 1 | 2024 | 39 | 0.210 |
Why?
|
| Bone Marrow Cells | 2 | 2017 | 237 | 0.210 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 7 | 0.210 |
Why?
|
| Gardenia | 1 | 2023 | 2 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 2237 | 0.210 |
Why?
|
| Lactobacillaceae | 1 | 2023 | 2 | 0.210 |
Why?
|
| Plankton | 1 | 2023 | 4 | 0.210 |
Why?
|
| Cattle | 2 | 2022 | 318 | 0.200 |
Why?
|
| Triterpenes | 2 | 2020 | 7 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2026 | 259 | 0.200 |
Why?
|
| Cysteine Endopeptidases | 1 | 2024 | 95 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 2 | 2025 | 70 | 0.200 |
Why?
|
| Vitamin E | 2 | 2017 | 55 | 0.200 |
Why?
|
| Thalamus | 1 | 2024 | 77 | 0.200 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2023 | 29 | 0.200 |
Why?
|
| Pedicle Screws | 1 | 2023 | 3 | 0.200 |
Why?
|
| Ganoderma | 1 | 2023 | 1 | 0.200 |
Why?
|
| Reishi | 1 | 2023 | 2 | 0.200 |
Why?
|
| Amino Acid Sequence | 4 | 2022 | 1589 | 0.200 |
Why?
|
| Sulfur Dioxide | 1 | 2023 | 1 | 0.200 |
Why?
|
| Electronic Nose | 2 | 2020 | 5 | 0.200 |
Why?
|
| Agaricus | 1 | 2023 | 1 | 0.200 |
Why?
|
| Nanotubes | 1 | 2023 | 24 | 0.200 |
Why?
|
| Bicarbonates | 1 | 2003 | 17 | 0.200 |
Why?
|
| Eicosanoids | 2 | 2023 | 25 | 0.200 |
Why?
|
| Cell Wall | 1 | 2024 | 117 | 0.200 |
Why?
|
| Fibrinolytic Agents | 1 | 2024 | 176 | 0.200 |
Why?
|
| Surface Properties | 6 | 2021 | 283 | 0.200 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2023 | 28 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 425 | 0.190 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 195 | 0.190 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 39 | 0.190 |
Why?
|
| Immunoglobulin E | 5 | 2023 | 81 | 0.190 |
Why?
|
| Health Promotion | 3 | 2023 | 512 | 0.190 |
Why?
|
| Dexamethasone | 2 | 2014 | 212 | 0.190 |
Why?
|
| Boron Compounds | 2 | 2015 | 22 | 0.190 |
Why?
|
| Protein Kinase C | 2 | 2013 | 102 | 0.190 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2013 | 94 | 0.190 |
Why?
|
| Precision Medicine | 1 | 2024 | 128 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 32 | 0.190 |
Why?
|
| Maillard Reaction | 2 | 2021 | 7 | 0.190 |
Why?
|
| Farms | 1 | 2022 | 4 | 0.190 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 261 | 0.190 |
Why?
|
| Colloids | 1 | 2022 | 50 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 297 | 0.190 |
Why?
|
| Coloring Agents | 1 | 2022 | 50 | 0.190 |
Why?
|
| Soil | 1 | 2022 | 27 | 0.190 |
Why?
|
| Bibliometrics | 1 | 2022 | 35 | 0.190 |
Why?
|
| Estrogen Receptor alpha | 2 | 2013 | 49 | 0.190 |
Why?
|
| Acetonitriles | 1 | 2022 | 2 | 0.190 |
Why?
|
| Fluorescence | 1 | 2022 | 93 | 0.190 |
Why?
|
| Orchidaceae | 1 | 2022 | 1 | 0.190 |
Why?
|
| Bepridil | 1 | 2002 | 2 | 0.190 |
Why?
|
| Osmolar Concentration | 2 | 2014 | 90 | 0.190 |
Why?
|
| Picrates | 1 | 2002 | 2 | 0.190 |
Why?
|
| Lycium | 1 | 2022 | 3 | 0.190 |
Why?
|
| Water Purification | 1 | 2022 | 9 | 0.180 |
Why?
|
| Leiomyoma | 2 | 2012 | 18 | 0.180 |
Why?
|
| Plants, Medicinal | 1 | 2022 | 19 | 0.180 |
Why?
|
| Alkenes | 1 | 2022 | 3 | 0.180 |
Why?
|
| Stereoisomerism | 2 | 2026 | 52 | 0.180 |
Why?
|
| Sodium Hydroxide | 1 | 2022 | 2 | 0.180 |
Why?
|
| Gestational Age | 2 | 2020 | 192 | 0.180 |
Why?
|
| Overweight | 1 | 2024 | 256 | 0.180 |
Why?
|
| Sperm Capacitation | 1 | 2003 | 97 | 0.180 |
Why?
|
| Infant, Premature | 1 | 2024 | 196 | 0.180 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2022 | 6 | 0.180 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2023 | 151 | 0.180 |
Why?
|
| Anthocyanins | 1 | 2022 | 15 | 0.180 |
Why?
|
| Hydrostatic Pressure | 1 | 2021 | 4 | 0.180 |
Why?
|
| Uterine Neoplasms | 2 | 2012 | 36 | 0.180 |
Why?
|
| Photoacoustic Techniques | 1 | 2021 | 4 | 0.180 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2019 | 28 | 0.180 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2022 | 277 | 0.180 |
Why?
|
| Loperamide | 1 | 2021 | 1 | 0.180 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 133 | 0.180 |
Why?
|
| Pandemics | 3 | 2023 | 669 | 0.180 |
Why?
|
| Adult | 10 | 2025 | 17271 | 0.180 |
Why?
|
| Polystyrenes | 1 | 2022 | 35 | 0.180 |
Why?
|
| Nutritional Status | 1 | 2022 | 100 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2019 | 205 | 0.180 |
Why?
|
| Gastrointestinal Motility | 1 | 2021 | 11 | 0.180 |
Why?
|
| Gastrointestinal Transit | 1 | 2021 | 6 | 0.180 |
Why?
|
| Toluene | 1 | 2021 | 8 | 0.180 |
Why?
|
| Lutein | 1 | 2021 | 22 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 582 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 191 | 0.180 |
Why?
|
| Disulfides | 1 | 2021 | 67 | 0.170 |
Why?
|
| In Vitro Techniques | 3 | 2020 | 491 | 0.170 |
Why?
|
| Mast Cells | 2 | 2019 | 51 | 0.170 |
Why?
|
| Pharmaceutical Preparations | 3 | 2024 | 120 | 0.170 |
Why?
|
| Activating Transcription Factors | 1 | 2021 | 11 | 0.170 |
Why?
|
| Pediococcus pentosaceus | 1 | 2021 | 2 | 0.170 |
Why?
|
| Hydrolysis | 4 | 2024 | 147 | 0.170 |
Why?
|
| Interferon-gamma | 1 | 2023 | 574 | 0.170 |
Why?
|
| Proteolipids | 1 | 2021 | 23 | 0.170 |
Why?
|
| Sodium Channels | 2 | 2011 | 26 | 0.170 |
Why?
|
| Stress, Mechanical | 2 | 2026 | 113 | 0.170 |
Why?
|
| Hydrogen Sulfide | 3 | 2015 | 9 | 0.170 |
Why?
|
| Rhizopus | 1 | 2021 | 5 | 0.170 |
Why?
|
| Alginates | 2 | 2019 | 50 | 0.170 |
Why?
|
| PC12 Cells | 2 | 2018 | 27 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2026 | 120 | 0.170 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 226 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 293 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 203 | 0.170 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2018 | 37 | 0.170 |
Why?
|
| Neuroblastoma | 1 | 2021 | 54 | 0.170 |
Why?
|
| Powders | 1 | 2020 | 21 | 0.170 |
Why?
|
| Species Specificity | 2 | 2018 | 339 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2025 | 718 | 0.170 |
Why?
|
| Glutathione Peroxidase | 1 | 2020 | 28 | 0.170 |
Why?
|
| Cell Culture Techniques | 3 | 2020 | 195 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2019 | 80 | 0.170 |
Why?
|
| Pyroptosis | 1 | 2021 | 38 | 0.170 |
Why?
|
| Glycogen | 1 | 2020 | 40 | 0.170 |
Why?
|
| Mucins | 2 | 2019 | 27 | 0.160 |
Why?
|
| Poria | 1 | 2020 | 1 | 0.160 |
Why?
|
| Hyperthyroidism | 1 | 2020 | 19 | 0.160 |
Why?
|
| Liver Diseases | 1 | 2022 | 158 | 0.160 |
Why?
|
| Neuralgia | 1 | 2020 | 21 | 0.160 |
Why?
|
| Swimming | 1 | 2020 | 30 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 105 | 0.160 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2018 | 76 | 0.160 |
Why?
|
| Monokines | 1 | 2020 | 4 | 0.160 |
Why?
|
| Zebrafish | 1 | 2024 | 368 | 0.160 |
Why?
|
| Carbohydrate Conformation | 1 | 2020 | 17 | 0.160 |
Why?
|
| Celecoxib | 3 | 2010 | 12 | 0.160 |
Why?
|
| Lactase | 1 | 2020 | 3 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 446 | 0.160 |
Why?
|
| Batch Cell Culture Techniques | 1 | 2020 | 6 | 0.160 |
Why?
|
| Body Weight | 2 | 2020 | 375 | 0.160 |
Why?
|
| Food Contamination | 1 | 2020 | 23 | 0.160 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 6 | 0.160 |
Why?
|
| Dendritic Spines | 1 | 2020 | 12 | 0.160 |
Why?
|
| Bacterial Translocation | 1 | 2020 | 10 | 0.160 |
Why?
|
| Clostridium Infections | 1 | 2021 | 49 | 0.160 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 81 | 0.160 |
Why?
|
| Enzyme Stability | 2 | 2018 | 47 | 0.160 |
Why?
|
| Hypothyroidism | 1 | 2020 | 43 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 119 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2020 | 21 | 0.160 |
Why?
|
| Sus scrofa | 2 | 2017 | 30 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 28 | 0.160 |
Why?
|
| Carbanilides | 1 | 2019 | 3 | 0.160 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2025 | 447 | 0.160 |
Why?
|
| Maternal Exposure | 1 | 2020 | 43 | 0.160 |
Why?
|
| Retinoid X Receptors | 2 | 2017 | 10 | 0.160 |
Why?
|
| Tuna | 1 | 2019 | 4 | 0.160 |
Why?
|
| Diet, Fat-Restricted | 2 | 2017 | 34 | 0.160 |
Why?
|
| Lysine | 1 | 2020 | 94 | 0.160 |
Why?
|
| Fermented Foods | 1 | 2019 | 6 | 0.160 |
Why?
|
| Microbial Viability | 1 | 2020 | 56 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 94 | 0.160 |
Why?
|
| Stichopus | 1 | 2019 | 1 | 0.150 |
Why?
|
| Serotonin | 2 | 2020 | 62 | 0.150 |
Why?
|
| Centrifugation | 1 | 2019 | 10 | 0.150 |
Why?
|
| NAD | 1 | 2020 | 53 | 0.150 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2019 | 42 | 0.150 |
Why?
|
| Enzyme Induction | 3 | 2006 | 25 | 0.150 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 3 | 0.150 |
Why?
|
| Chondroitin Sulfates | 1 | 2019 | 11 | 0.150 |
Why?
|
| gamma-Tocopherol | 2 | 2010 | 3 | 0.150 |
Why?
|
| Lipid Bilayers | 1 | 2019 | 53 | 0.150 |
Why?
|
| Penaeidae | 1 | 2019 | 10 | 0.150 |
Why?
|
| Psidium | 1 | 2019 | 1 | 0.150 |
Why?
|
| Red Meat | 1 | 2019 | 10 | 0.150 |
Why?
|
| Molecular Docking Simulation | 3 | 2026 | 81 | 0.150 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2019 | 3 | 0.150 |
Why?
|
| Carbohydrate Sequence | 1 | 2019 | 21 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2021 | 110 | 0.150 |
Why?
|
| Circular Dichroism | 1 | 2019 | 108 | 0.150 |
Why?
|
| Streptozocin | 1 | 2019 | 23 | 0.150 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 1160 | 0.150 |
Why?
|
| Tilapia | 1 | 2019 | 2 | 0.150 |
Why?
|
| Benzophenones | 1 | 2019 | 20 | 0.150 |
Why?
|
| beta Catenin | 3 | 2018 | 99 | 0.150 |
Why?
|
| Sapindaceae | 1 | 2019 | 1 | 0.150 |
Why?
|
| Arginine | 1 | 2020 | 136 | 0.150 |
Why?
|
| Air Microbiology | 1 | 2019 | 11 | 0.150 |
Why?
|
| Fires | 1 | 2019 | 17 | 0.150 |
Why?
|
| Camellia sinensis | 1 | 2019 | 3 | 0.150 |
Why?
|
| Spores, Fungal | 1 | 2019 | 22 | 0.150 |
Why?
|
| Space Flight | 1 | 2019 | 20 | 0.150 |
Why?
|
| Bacterial Adhesion | 1 | 2019 | 65 | 0.150 |
Why?
|
| Mouth | 1 | 2019 | 35 | 0.150 |
Why?
|
| Biflavonoids | 1 | 2019 | 8 | 0.150 |
Why?
|
| Biological Evolution | 1 | 2020 | 127 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 226 | 0.150 |
Why?
|
| A549 Cells | 1 | 2019 | 39 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2018 | 415 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2024 | 569 | 0.150 |
Why?
|
| Seeds | 1 | 2019 | 29 | 0.150 |
Why?
|
| Autophagy | 2 | 2018 | 231 | 0.150 |
Why?
|
| Intestinal Neoplasms | 1 | 2018 | 15 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2026 | 203 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2020 | 135 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 895 | 0.140 |
Why?
|
| Antlers | 1 | 2018 | 1 | 0.140 |
Why?
|
| Ion Channel Gating | 1 | 2018 | 44 | 0.140 |
Why?
|
| Burns | 1 | 2019 | 45 | 0.140 |
Why?
|
| Benzethonium | 1 | 2018 | 2 | 0.140 |
Why?
|
| Xylenes | 1 | 2018 | 4 | 0.140 |
Why?
|
| Benzalkonium Compounds | 1 | 2018 | 5 | 0.140 |
Why?
|
| Cytochromes c | 2 | 2015 | 28 | 0.140 |
Why?
|
| Adolescent | 3 | 2025 | 6280 | 0.140 |
Why?
|
| Child | 3 | 2024 | 4601 | 0.140 |
Why?
|
| Saponins | 2 | 2020 | 26 | 0.140 |
Why?
|
| Acetic Acid | 1 | 2018 | 10 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 790 | 0.140 |
Why?
|
| Biocatalysis | 1 | 2018 | 50 | 0.140 |
Why?
|
| Egg Proteins | 1 | 2018 | 24 | 0.140 |
Why?
|
| Nonlinear Optical Microscopy | 1 | 2017 | 1 | 0.140 |
Why?
|
| Cocos | 1 | 2017 | 2 | 0.140 |
Why?
|
| Mortality | 1 | 2019 | 159 | 0.140 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2017 | 12 | 0.130 |
Why?
|
| Wound Healing | 1 | 2019 | 193 | 0.130 |
Why?
|
| Ginkgolides | 1 | 2017 | 1 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2017 | 42 | 0.130 |
Why?
|
| Listeria monocytogenes | 1 | 2017 | 33 | 0.130 |
Why?
|
| Anaphylaxis | 2 | 2019 | 41 | 0.130 |
Why?
|
| Gram-Negative Bacteria | 1 | 2017 | 56 | 0.130 |
Why?
|
| Toxicology | 1 | 2017 | 22 | 0.130 |
Why?
|
| Lactones | 1 | 2017 | 16 | 0.130 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 39 | 0.130 |
Why?
|
| Vitamin D | 1 | 2018 | 139 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.130 |
Why?
|
| Meningocele | 1 | 2017 | 4 | 0.130 |
Why?
|
| Peptide Mapping | 1 | 2017 | 29 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2015 | 140 | 0.130 |
Why?
|
| Receptors, sigma | 1 | 2017 | 1 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 218 | 0.130 |
Why?
|
| Renin-Angiotensin System | 1 | 2017 | 22 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 152 | 0.130 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2017 | 8 | 0.130 |
Why?
|
| Carboxylic Acids | 1 | 2017 | 9 | 0.130 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2017 | 17 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2026 | 1216 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2017 | 83 | 0.130 |
Why?
|
| Aspirin | 2 | 2008 | 171 | 0.130 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2017 | 45 | 0.130 |
Why?
|
| Protein Binding | 4 | 2023 | 1638 | 0.130 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 56 | 0.120 |
Why?
|
| Somatomedins | 1 | 2016 | 4 | 0.120 |
Why?
|
| Craniocerebral Trauma | 1 | 2017 | 53 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2017 | 483 | 0.120 |
Why?
|
| Cells | 1 | 2016 | 32 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1134 | 0.120 |
Why?
|
| Hydroquinones | 1 | 2016 | 8 | 0.120 |
Why?
|
| Serum Albumin, Human | 1 | 2016 | 7 | 0.120 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 19 | 0.120 |
Why?
|
| Perioperative Period | 1 | 2016 | 20 | 0.120 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2016 | 3 | 0.120 |
Why?
|
| Hypertrophy | 1 | 2016 | 29 | 0.120 |
Why?
|
| Inactivation, Metabolic | 1 | 2016 | 14 | 0.120 |
Why?
|
| Biomechanical Phenomena | 3 | 2026 | 283 | 0.120 |
Why?
|
| Estrogens | 2 | 2015 | 116 | 0.120 |
Why?
|
| Mangifera | 1 | 2016 | 2 | 0.120 |
Why?
|
| Troponin I | 1 | 2016 | 36 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 61 | 0.120 |
Why?
|
| Kynurenine | 1 | 2016 | 7 | 0.120 |
Why?
|
| Static Electricity | 2 | 2014 | 170 | 0.120 |
Why?
|
| Naphthalenes | 1 | 2015 | 17 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 93 | 0.120 |
Why?
|
| Gravitation | 1 | 2015 | 10 | 0.120 |
Why?
|
| Database Management Systems | 1 | 2015 | 20 | 0.120 |
Why?
|
| Dermatitis | 1 | 2015 | 27 | 0.120 |
Why?
|
| Tensile Strength | 1 | 2015 | 32 | 0.120 |
Why?
|
| Lymphangiogenesis | 1 | 2015 | 14 | 0.120 |
Why?
|
| Annexin A5 | 2 | 2014 | 20 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2015 | 94 | 0.110 |
Why?
|
| Pilot Projects | 2 | 2025 | 1009 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2025 | 287 | 0.110 |
Why?
|
| Ketoglutaric Acids | 1 | 2015 | 7 | 0.110 |
Why?
|
| Seawater | 2 | 2025 | 10 | 0.110 |
Why?
|
| Oils | 3 | 2022 | 72 | 0.110 |
Why?
|
| Cystatin C | 1 | 2015 | 9 | 0.110 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2019 | 42 | 0.110 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2012 | 22 | 0.110 |
Why?
|
| Models, Neurological | 1 | 2015 | 83 | 0.110 |
Why?
|
| ErbB Receptors | 2 | 2017 | 127 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 402 | 0.110 |
Why?
|
| Intestinal Secretions | 1 | 2014 | 4 | 0.110 |
Why?
|
| Pesticide Residues | 1 | 2014 | 7 | 0.110 |
Why?
|
| Crystallization | 1 | 2015 | 98 | 0.110 |
Why?
|
| alpha-Tocopherol | 1 | 2014 | 18 | 0.110 |
Why?
|
| Food, Fortified | 1 | 2014 | 19 | 0.110 |
Why?
|
| Protein Hydrolysates | 1 | 2014 | 5 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2014 | 28 | 0.110 |
Why?
|
| Perciformes | 1 | 2014 | 4 | 0.110 |
Why?
|
| Hypovolemia | 1 | 2014 | 17 | 0.110 |
Why?
|
| Chelating Agents | 1 | 2014 | 49 | 0.110 |
Why?
|
| Hernia | 1 | 2014 | 14 | 0.110 |
Why?
|
| Sertoli Cells | 1 | 2014 | 13 | 0.110 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 6 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 42 | 0.110 |
Why?
|
| Sodium Selenite | 1 | 2014 | 1 | 0.110 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2014 | 17 | 0.110 |
Why?
|
| Freeze Drying | 1 | 2014 | 15 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 46 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 44 | 0.110 |
Why?
|
| Genotype | 3 | 2023 | 672 | 0.110 |
Why?
|
| Models, Molecular | 3 | 2026 | 1159 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 29 | 0.100 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2014 | 32 | 0.100 |
Why?
|
| Microsurgery | 1 | 2014 | 54 | 0.100 |
Why?
|
| Sepharose | 2 | 2023 | 7 | 0.100 |
Why?
|
| Interleukin-8 | 3 | 2019 | 95 | 0.100 |
Why?
|
| Cefuroxime | 2 | 2024 | 2 | 0.100 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2013 | 2 | 0.100 |
Why?
|
| Levofloxacin | 2 | 2024 | 13 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2014 | 125 | 0.100 |
Why?
|
| Cadmium | 2 | 2024 | 12 | 0.100 |
Why?
|
| Capsaicin | 1 | 2013 | 19 | 0.100 |
Why?
|
| Panax notoginseng | 1 | 2013 | 1 | 0.100 |
Why?
|
| Ginsenosides | 1 | 2013 | 2 | 0.100 |
Why?
|
| Energy Metabolism | 3 | 2025 | 395 | 0.100 |
Why?
|
| Drainage | 1 | 2014 | 152 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 51 | 0.100 |
Why?
|
| Maleimides | 1 | 2013 | 9 | 0.100 |
Why?
|
| Tetraethylammonium | 1 | 2013 | 9 | 0.100 |
Why?
|
| Tetrodotoxin | 1 | 2013 | 11 | 0.100 |
Why?
|
| Desiccation | 2 | 2026 | 8 | 0.100 |
Why?
|
| Sodium Channel Blockers | 1 | 2013 | 12 | 0.100 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2013 | 2 | 0.100 |
Why?
|
| Potassium Channel Blockers | 1 | 2013 | 23 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 18 | 0.100 |
Why?
|
| Organoselenium Compounds | 1 | 2013 | 3 | 0.100 |
Why?
|
| Isoquinolines | 1 | 2013 | 30 | 0.100 |
Why?
|
| Adenoma | 2 | 2010 | 68 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2013 | 37 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 4 | 0.100 |
Why?
|
| Biophysics | 1 | 2013 | 42 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 61 | 0.100 |
Why?
|
| Enzyme Activation | 4 | 2016 | 391 | 0.100 |
Why?
|
| Albumins | 1 | 2013 | 43 | 0.100 |
Why?
|
| Electric Stimulation | 1 | 2013 | 139 | 0.100 |
Why?
|
| Hydroxylation | 2 | 2010 | 10 | 0.100 |
Why?
|
| Quercetin | 1 | 2012 | 27 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2013 | 124 | 0.090 |
Why?
|
| Analgesics | 1 | 2013 | 102 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 84 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 32 | 0.090 |
Why?
|
| Fibrosis | 1 | 2013 | 172 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2014 | 189 | 0.090 |
Why?
|
| Genistein | 1 | 2012 | 9 | 0.090 |
Why?
|
| Biomass | 2 | 2024 | 20 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 96 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2012 | 17 | 0.090 |
Why?
|
| Lethal Dose 50 | 1 | 2012 | 16 | 0.090 |
Why?
|
| Biogenic Amines | 1 | 2012 | 2 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2012 | 11 | 0.090 |
Why?
|
| Pyridines | 2 | 2013 | 116 | 0.090 |
Why?
|
| Hydrogen Peroxide | 3 | 2017 | 82 | 0.090 |
Why?
|
| Porosity | 2 | 2024 | 41 | 0.090 |
Why?
|
| Activins | 1 | 2012 | 55 | 0.090 |
Why?
|
| Sperm Motility | 1 | 2012 | 51 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2025 | 270 | 0.090 |
Why?
|
| Estrogen Receptor beta | 1 | 2011 | 24 | 0.090 |
Why?
|
| PPAR alpha | 2 | 2025 | 33 | 0.090 |
Why?
|
| Organ Size | 1 | 2012 | 173 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2012 | 103 | 0.090 |
Why?
|
| Drug Storage | 2 | 2022 | 23 | 0.090 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 15 | 0.090 |
Why?
|
| Nitrogen | 2 | 2024 | 21 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 2 | 2023 | 217 | 0.090 |
Why?
|
| Epitope Mapping | 2 | 2023 | 52 | 0.090 |
Why?
|
| Interleukin-1 | 1 | 2012 | 154 | 0.090 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 325 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 181 | 0.090 |
Why?
|
| Estrogen Antagonists | 1 | 2011 | 16 | 0.080 |
Why?
|
| Phenotype | 3 | 2024 | 1231 | 0.080 |
Why?
|
| Testis | 1 | 2012 | 160 | 0.080 |
Why?
|
| Cadherins | 1 | 2011 | 90 | 0.080 |
Why?
|
| Cryoelectron Microscopy | 2 | 2023 | 217 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 31 | 0.080 |
Why?
|
| Podophyllotoxin | 1 | 2010 | 1 | 0.080 |
Why?
|
| Ganglia, Invertebrate | 1 | 2010 | 5 | 0.080 |
Why?
|
| Environmental Pollution | 2 | 2021 | 14 | 0.080 |
Why?
|
| Aberrant Crypt Foci | 1 | 2010 | 1 | 0.080 |
Why?
|
| Monocytes | 1 | 2013 | 360 | 0.080 |
Why?
|
| Kidney | 1 | 2013 | 450 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2012 | 340 | 0.080 |
Why?
|
| Protein Conformation, alpha-Helical | 2 | 2022 | 22 | 0.080 |
Why?
|
| Pressure | 2 | 2024 | 78 | 0.080 |
Why?
|
| Neural Conduction | 1 | 2010 | 32 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 52 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 52 | 0.080 |
Why?
|
| Adipose Tissue | 2 | 2025 | 299 | 0.080 |
Why?
|
| Sciatic Nerve | 1 | 2010 | 29 | 0.080 |
Why?
|
| Chromans | 1 | 2010 | 16 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1689 | 0.080 |
Why?
|
| Polyphosphates | 1 | 2010 | 13 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 698 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 213 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 896 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 12 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2026 | 790 | 0.080 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2010 | 45 | 0.080 |
Why?
|
| Benzo(a)pyrene | 2 | 2025 | 4 | 0.080 |
Why?
|
| Risk Factors | 2 | 2017 | 5401 | 0.080 |
Why?
|
| Chickens | 2 | 2021 | 94 | 0.080 |
Why?
|
| Necrosis | 1 | 2010 | 148 | 0.080 |
Why?
|
| Trisaccharides | 2 | 2019 | 8 | 0.080 |
Why?
|
| Maltose | 2 | 2019 | 12 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 52 | 0.080 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 117 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 197 | 0.070 |
Why?
|
| Aged | 4 | 2023 | 14879 | 0.070 |
Why?
|
| Swine | 2 | 2023 | 394 | 0.070 |
Why?
|
| Dantrolene | 1 | 2009 | 8 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 36 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 636 | 0.070 |
Why?
|
| Hot Temperature | 3 | 2019 | 144 | 0.070 |
Why?
|
| Calorimetry, Differential Scanning | 2 | 2021 | 31 | 0.070 |
Why?
|
| Lovastatin | 1 | 2008 | 2 | 0.070 |
Why?
|
| Pravastatin | 1 | 2008 | 3 | 0.070 |
Why?
|
| Sulindac | 1 | 2008 | 5 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 405 | 0.070 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 6 | 0.070 |
Why?
|
| Simvastatin | 1 | 2008 | 26 | 0.070 |
Why?
|
| Leukotriene B4 | 3 | 2017 | 12 | 0.070 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2008 | 11 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 513 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 108 | 0.070 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2021 | 44 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2011 | 531 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 78 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 662 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2008 | 46 | 0.070 |
Why?
|
| G1 Phase | 1 | 2008 | 58 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2008 | 202 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 294 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2025 | 6823 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2021 | 290 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 542 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 94 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2010 | 331 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2020 | 52 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 790 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 799 | 0.060 |
Why?
|
| Histamine | 2 | 2019 | 21 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 980 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2024 | 1412 | 0.060 |
Why?
|
| Interleukin-10 | 2 | 2019 | 164 | 0.060 |
Why?
|
| Angiotensin II | 2 | 2017 | 25 | 0.060 |
Why?
|
| Sulfonic Acids | 2 | 2023 | 11 | 0.060 |
Why?
|
| Annexin A2 | 1 | 2026 | 7 | 0.060 |
Why?
|
| Benzothiazoles | 2 | 2023 | 20 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2026 | 18 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 456 | 0.060 |
Why?
|
| Freezing | 1 | 2026 | 21 | 0.060 |
Why?
|
| Flour | 1 | 2026 | 11 | 0.060 |
Why?
|
| Models, Animal | 2 | 2019 | 241 | 0.060 |
Why?
|
| Jejunum | 1 | 2026 | 15 | 0.060 |
Why?
|
| Pupa | 1 | 2026 | 18 | 0.060 |
Why?
|
| United States | 1 | 2019 | 8058 | 0.060 |
Why?
|
| Protein Aggregates | 1 | 2026 | 24 | 0.060 |
Why?
|
| Food Preservation | 1 | 2025 | 19 | 0.060 |
Why?
|
| Duodenum | 1 | 2026 | 41 | 0.060 |
Why?
|
| Climate | 1 | 2025 | 8 | 0.060 |
Why?
|
| Janus Kinase 2 | 1 | 2025 | 21 | 0.060 |
Why?
|
| Host Specificity | 1 | 2025 | 11 | 0.060 |
Why?
|
| Base Composition | 1 | 2025 | 30 | 0.060 |
Why?
|
| Bone Plates | 1 | 2026 | 41 | 0.060 |
Why?
|
| Rheology | 1 | 2026 | 83 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 731 | 0.060 |
Why?
|
| Hydrocarbons | 1 | 2025 | 10 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2026 | 113 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 1 | 2025 | 35 | 0.060 |
Why?
|
| Metabolic Engineering | 1 | 2025 | 9 | 0.060 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2025 | 44 | 0.060 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2025 | 21 | 0.060 |
Why?
|
| Lignin | 1 | 2024 | 4 | 0.060 |
Why?
|
| Hydrodynamics | 1 | 2025 | 43 | 0.060 |
Why?
|
| Thermal Conductivity | 1 | 2024 | 5 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2026 | 129 | 0.050 |
Why?
|
| Anaerobiosis | 1 | 2024 | 13 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2017 | 130 | 0.050 |
Why?
|
| Inulin | 1 | 2024 | 3 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2024 | 5773 | 0.050 |
Why?
|
| Anthracenes | 2 | 2015 | 10 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 179 | 0.050 |
Why?
|
| Proteolysis | 1 | 2025 | 154 | 0.050 |
Why?
|
| Carotid Artery, Internal, Dissection | 1 | 2024 | 19 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2025 | 71 | 0.050 |
Why?
|
| Household Products | 1 | 2024 | 4 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2024 | 11 | 0.050 |
Why?
|
| Patents as Topic | 1 | 2024 | 6 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2024 | 71 | 0.050 |
Why?
|
| Wetlands | 1 | 2024 | 1 | 0.050 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2024 | 51 | 0.050 |
Why?
|
| Geologic Sediments | 1 | 2024 | 4 | 0.050 |
Why?
|
| Peroxidase | 1 | 2024 | 70 | 0.050 |
Why?
|
| Multimedia | 1 | 2024 | 9 | 0.050 |
Why?
|
| Luminescent Agents | 1 | 2024 | 6 | 0.050 |
Why?
|
| Nanofibers | 1 | 2024 | 20 | 0.050 |
Why?
|
| Azides | 1 | 2024 | 22 | 0.050 |
Why?
|
| Chalcones | 1 | 2023 | 1 | 0.050 |
Why?
|
| Bismuth | 1 | 2023 | 4 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2024 | 69 | 0.050 |
Why?
|
| Acetone | 1 | 2023 | 5 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 151 | 0.050 |
Why?
|
| Cholestanol | 1 | 2023 | 1 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Alkynes | 1 | 2024 | 28 | 0.050 |
Why?
|
| Pyrenes | 1 | 2023 | 4 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 9 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2024 | 41 | 0.050 |
Why?
|
| Citric Acid | 1 | 2023 | 20 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Infant | 2 | 2019 | 1680 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2025 | 272 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 79 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2024 | 126 | 0.050 |
Why?
|
| Alphapapillomavirus | 1 | 2023 | 19 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2005 | 176 | 0.050 |
Why?
|
| Biomimetics | 1 | 2023 | 31 | 0.050 |
Why?
|
| Stroke | 1 | 2013 | 1207 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2023 | 2 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2023 | 59 | 0.050 |
Why?
|
| Ecosystem | 1 | 2024 | 57 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2021 | 430 | 0.050 |
Why?
|
| Food Safety | 1 | 2023 | 10 | 0.050 |
Why?
|
| Buffers | 1 | 2003 | 22 | 0.050 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2023 | 1 | 0.050 |
Why?
|
| Vertebral Artery | 1 | 2023 | 29 | 0.050 |
Why?
|
| Urban Population | 1 | 2024 | 200 | 0.050 |
Why?
|
| Least-Squares Analysis | 1 | 2023 | 24 | 0.050 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2023 | 18 | 0.050 |
Why?
|
| Eubacterium | 1 | 2023 | 2 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 233 | 0.050 |
Why?
|
| Vitis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Wine | 1 | 2023 | 3 | 0.050 |
Why?
|
| Fungi | 1 | 2023 | 56 | 0.050 |
Why?
|
| Spectrum Analysis | 1 | 2023 | 50 | 0.050 |
Why?
|
| Beta vulgaris | 1 | 2002 | 7 | 0.050 |
Why?
|
| Rabbits | 1 | 2023 | 338 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2024 | 111 | 0.050 |
Why?
|
| Pigments, Biological | 1 | 2002 | 6 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2023 | 73 | 0.050 |
Why?
|
| Thiamphenicol | 1 | 2022 | 1 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2023 | 75 | 0.050 |
Why?
|
| Premature Birth | 1 | 2024 | 114 | 0.050 |
Why?
|
| Immunization | 1 | 2023 | 135 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2694 | 0.050 |
Why?
|
| Hydrogels | 1 | 2024 | 126 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2005 | 309 | 0.050 |
Why?
|
| Hydroxides | 1 | 2022 | 5 | 0.050 |
Why?
|
| Singlet Oxygen | 1 | 2002 | 2 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 107 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2002 | 8 | 0.050 |
Why?
|
| RNA, Plant | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sugars | 1 | 2022 | 5 | 0.050 |
Why?
|
| Superoxides | 1 | 2002 | 73 | 0.050 |
Why?
|
| Biphenyl Compounds | 1 | 2002 | 30 | 0.050 |
Why?
|
| Anions | 1 | 2022 | 32 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 114 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2022 | 10 | 0.050 |
Why?
|
| Furin | 1 | 2021 | 10 | 0.040 |
Why?
|
| Metagenomics | 1 | 2022 | 29 | 0.040 |
Why?
|
| Polyesters | 1 | 2022 | 45 | 0.040 |
Why?
|
| Transfection | 2 | 2017 | 700 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 176 | 0.040 |
Why?
|
| Infrared Rays | 1 | 2021 | 19 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2022 | 86 | 0.040 |
Why?
|
| Nitrites | 1 | 2021 | 12 | 0.040 |
Why?
|
| Chromatography | 1 | 2021 | 15 | 0.040 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 6 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 55 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2021 | 38 | 0.040 |
Why?
|
| Vitamins | 1 | 2021 | 80 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 39 | 0.040 |
Why?
|
| Animal Feed | 1 | 2021 | 15 | 0.040 |
Why?
|
| Insecta | 1 | 2021 | 36 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2020 | 13 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2020 | 15 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 219 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2020 | 18 | 0.040 |
Why?
|
| Meat | 1 | 2021 | 38 | 0.040 |
Why?
|
| Nisin | 1 | 2020 | 2 | 0.040 |
Why?
|
| Streptococcus thermophilus | 1 | 2020 | 3 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 12 | 0.040 |
Why?
|
| Lactose | 1 | 2020 | 10 | 0.040 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2020 | 5 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 1267 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2020 | 40 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2020 | 49 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 285 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 209 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2021 | 198 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2021 | 77 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 373 | 0.040 |
Why?
|
| Deoxyguanosine | 2 | 2010 | 19 | 0.040 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2020 | 22 | 0.040 |
Why?
|
| Culture Media | 1 | 2020 | 78 | 0.040 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2019 | 4 | 0.040 |
Why?
|
| Milk | 1 | 2020 | 47 | 0.040 |
Why?
|
| Basophils | 1 | 2019 | 15 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2020 | 92 | 0.040 |
Why?
|
| Fresh Water | 1 | 2019 | 13 | 0.040 |
Why?
|
| Demethylation | 1 | 2019 | 4 | 0.040 |
Why?
|
| Ethanol | 2 | 2019 | 329 | 0.040 |
Why?
|
| Disease Progression | 1 | 2024 | 1214 | 0.040 |
Why?
|
| Weather | 1 | 2019 | 10 | 0.040 |
Why?
|
| Nitrates | 1 | 2019 | 21 | 0.040 |
Why?
|
| Sugar Alcohols | 1 | 2019 | 1 | 0.040 |
Why?
|
| Prognosis | 1 | 2024 | 1774 | 0.040 |
Why?
|
| Serratia | 1 | 2019 | 3 | 0.040 |
Why?
|
| Pseudomonas | 1 | 2019 | 8 | 0.040 |
Why?
|
| Oxygen | 1 | 2021 | 317 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2020 | 207 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 31 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2019 | 30 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1438 | 0.040 |
Why?
|
| Clotrimazole | 1 | 2019 | 3 | 0.040 |
Why?
|
| Proadifen | 1 | 2019 | 3 | 0.040 |
Why?
|
| Steam | 1 | 2019 | 6 | 0.040 |
Why?
|
| Binding Sites | 1 | 2022 | 920 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 735 | 0.040 |
Why?
|
| Epidermis | 1 | 2019 | 35 | 0.040 |
Why?
|
| Tyrosine | 2 | 2010 | 93 | 0.040 |
Why?
|
| Citrus paradisi | 1 | 2018 | 1 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 364 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2019 | 50 | 0.040 |
Why?
|
| Enteritis | 1 | 2018 | 13 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2018 | 22 | 0.040 |
Why?
|
| Solutions | 1 | 2018 | 63 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 299 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 269 | 0.040 |
Why?
|
| Fractals | 1 | 2018 | 8 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2017 | 912 | 0.040 |
Why?
|
| Deer | 1 | 2018 | 12 | 0.040 |
Why?
|
| Consumer Product Safety | 1 | 2018 | 12 | 0.040 |
Why?
|
| Anisotropy | 1 | 2018 | 63 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 66 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2018 | 22 | 0.030 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2018 | 7 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 181 | 0.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2018 | 18 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 302 | 0.030 |
Why?
|
| Autophagosomes | 1 | 2018 | 13 | 0.030 |
Why?
|
| Colostrum | 1 | 2018 | 6 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 37 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 233 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 22 | 0.030 |
Why?
|
| Macrolides | 1 | 2018 | 37 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2017 | 26 | 0.030 |
Why?
|
| Materials Testing | 1 | 2018 | 88 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 22 | 0.030 |
Why?
|
| Toxicokinetics | 1 | 2017 | 2 | 0.030 |
Why?
|
| Levivirus | 1 | 2017 | 1 | 0.030 |
Why?
|
| Salmonella Food Poisoning | 1 | 2017 | 3 | 0.030 |
Why?
|
| Membrane Fusion | 1 | 2018 | 67 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2017 | 18 | 0.030 |
Why?
|
| T-Phages | 1 | 2017 | 6 | 0.030 |
Why?
|
| Sirolimus | 1 | 2018 | 93 | 0.030 |
Why?
|
| Listeriosis | 1 | 2017 | 29 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 114 | 0.030 |
Why?
|
| Carps | 1 | 2017 | 1 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2017 | 62 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 1653 | 0.030 |
Why?
|
| Arachnoid | 1 | 2017 | 1 | 0.030 |
Why?
|
| Weaning | 1 | 2017 | 7 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 464 | 0.030 |
Why?
|
| Sulfur | 1 | 2017 | 16 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2021 | 347 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 167 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 145 | 0.030 |
Why?
|
| Myofibrils | 1 | 2017 | 19 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2017 | 7 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 87 | 0.030 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 29 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2017 | 46 | 0.030 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 23 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 907 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2017 | 87 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 33 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 372 | 0.030 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Amplified Fragment Length Polymorphism Analysis | 1 | 2016 | 1 | 0.030 |
Why?
|
| Histones | 2 | 2010 | 494 | 0.030 |
Why?
|
| Vitamin A Deficiency | 1 | 2016 | 3 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 500 | 0.030 |
Why?
|
| Pain | 1 | 2019 | 398 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 359 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2016 | 48 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 48 | 0.030 |
Why?
|
| Vitamin A | 1 | 2016 | 27 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 90 | 0.030 |
Why?
|
| Solid Phase Extraction | 1 | 2016 | 10 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 24 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1579 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Collagen | 1 | 2016 | 135 | 0.030 |
Why?
|
| Cooking | 1 | 2015 | 19 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2015 | 21 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 164 | 0.030 |
Why?
|
| Estrogen Receptor Antagonists | 1 | 2015 | 1 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 91 | 0.030 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2015 | 7 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2016 | 102 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2015 | 127 | 0.030 |
Why?
|
| Whey Proteins | 1 | 2015 | 70 | 0.030 |
Why?
|
| Sodium Cholate | 1 | 2014 | 2 | 0.030 |
Why?
|
| Triolein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Deoxycholic Acid | 1 | 2014 | 7 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 82 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 261 | 0.030 |
Why?
|
| Caprylates | 1 | 2014 | 15 | 0.030 |
Why?
|
| Aerobiosis | 1 | 2014 | 8 | 0.030 |
Why?
|
| Calcium Chloride | 1 | 2014 | 19 | 0.030 |
Why?
|
| Mifepristone | 1 | 2014 | 19 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 95 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 3300 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 103 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2014 | 28 | 0.030 |
Why?
|
| Coma | 1 | 2014 | 14 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2014 | 18 | 0.030 |
Why?
|
| Fishes | 1 | 2014 | 22 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 106 | 0.030 |
Why?
|
| Endopeptidases | 1 | 2014 | 67 | 0.030 |
Why?
|
| Caspase 7 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Amino Acids | 1 | 2015 | 148 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 65 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 104 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2013 | 37 | 0.030 |
Why?
|
| Caspase 6 | 1 | 2014 | 21 | 0.030 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2013 | 3 | 0.030 |
Why?
|
| Histamine Release | 1 | 2013 | 3 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2014 | 100 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2013 | 19 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2013 | 86 | 0.020 |
Why?
|
| Imidazoles | 1 | 2013 | 82 | 0.020 |
Why?
|
| Potassium Channels | 1 | 2013 | 55 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 89 | 0.020 |
Why?
|
| Dosage Forms | 1 | 2012 | 2 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 182 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 151 | 0.020 |
Why?
|
| Antimetabolites | 1 | 2012 | 18 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 43 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 128 | 0.020 |
Why?
|
| Risk | 1 | 2013 | 374 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 116 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2011 | 103 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 122 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 240 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 211 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 762 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 615 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 202 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 85 | 0.020 |
Why?
|
| Periplaneta | 1 | 2010 | 1 | 0.020 |
Why?
|
| Drosophila | 1 | 2014 | 480 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 151 | 0.020 |
Why?
|
| Endocytosis | 1 | 2011 | 152 | 0.020 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2010 | 4 | 0.020 |
Why?
|
| Mevalonic Acid | 1 | 2010 | 4 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2010 | 20 | 0.020 |
Why?
|
| Lipolysis | 1 | 2010 | 47 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2009 | 152 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 147 | 0.020 |
Why?
|
| Cocarcinogenesis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 428 | 0.020 |
Why?
|
| Dinoprost | 1 | 2009 | 19 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2008 | 4 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2008 | 22 | 0.020 |
Why?
|
| Sarcoma | 1 | 2008 | 36 | 0.020 |
Why?
|
| DNA Repair | 1 | 2010 | 251 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 292 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 661 | 0.020 |
Why?
|
| Caffeine | 1 | 2008 | 46 | 0.020 |
Why?
|
| Blueberry Plants | 1 | 2007 | 1 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 23 | 0.020 |
Why?
|
| Survival | 1 | 2005 | 11 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 364 | 0.010 |
Why?
|
| Metmyoglobin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Amidines | 1 | 2002 | 19 | 0.010 |
Why?
|
| Carbon-Sulfur Lyases | 1 | 2002 | 2 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 2002 | 17 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2002 | 128 | 0.010 |
Why?
|